drugset / Trial / NCT06455059
Interventional Study of Vosoritide for the Treatment of Children With Hypochondroplasia
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The intent and design of this Phase 3 study is to assess vosoritide as a therapeutic option for the treatment of children with hypochondroplasia (HCH).
Timeline
- Start
- 2024-06-17
- Primary completion
- 2026-08-01
- Completion
- 2026-08-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vosoritide | Peptide | — | Subcutaneous |